» Articles » PMID: 2856398

Tissue-specific Regulation of Pituitary Proopiomelanocortin Gene Transcription by Corticotropin-releasing Hormone, 3',5'-cyclic Adenosine Monophosphate, and Glucocorticoids

Overview
Journal Mol Endocrinol
Date 1987 Oct 1
PMID 2856398
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The release of pituitary hormones derived from POMC is under multihormonal and tissue-specific control in the anterior and intermediate lobes of the pituitary where the same single-copy POMC gene is expressed. In order to assess the tissue-specificity of POMC regulation at the gene level, we have previously shown that glucocorticoids inhibit POMC gene transcription in the anterior but not in the intermediate pituitary. In the present work, we have investigated the role of corticotropin-releasing hormone (CRH) and cAMP in the differential regulation of anterior and intermediate pituitary POMC gene transcription. Using pituitary cells in primary culture and nuclear run-on transcription assays, we found that cAMP increases POMC gene transcription rate to the same extent in both anterior and intermediate pituitary cells while CRH only increases anterior pituitary POMC transcription rate. This observation contrasts with the stimulation of ACTH and alpha MSH release from anterior and intermediate pituitary cells, respectively, by both CRH and cAMP. In the anterior pituitary, both CRH and cAMP stimulated as well as basal POMC transcription rates are inhibited by glucocorticoids. In the anterior pituitary, both CRH stimulation and glucocorticoid inhibition of POMC transcription are rapid and do not require de novo protein synthesis. Thus, we report that transcription of the POMC gene is differentially regulated by CRH, cAMP, and glucocorticoids in anterior and intermediate pituitary tissues, in much the same way as the control of POMC processing and release.

Citing Articles

POMC: The Physiological Power of Hormone Processing.

Harno E, Gali Ramamoorthy T, Coll A, White A Physiol Rev. 2018; 98(4):2381-2430.

PMID: 30156493 PMC: 6170974. DOI: 10.1152/physrev.00024.2017.


Dibutyryl-cAMP affecting fat deposition of finishing pigs by decreasing the inflammatory system related to insulin sensitive or lipolysis.

Ma X, Fang W, Jiang Z, Wang L, Yang X, Gao K Genes Nutr. 2016; 11:17.

PMID: 27551318 PMC: 4968439. DOI: 10.1186/s12263-016-0531-5.


TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.

Rambaud J, Desroches J, Balsalobre A, Drouin J J Biol Chem. 2009; 284(21):14147-56.

PMID: 19321449 PMC: 2682863. DOI: 10.1074/jbc.M809023200.


Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F Genes Dev. 2006; 20(20):2871-86.

PMID: 17043312 PMC: 1619949. DOI: 10.1101/gad.1444606.


Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment.

Maira M, Martens C, Batsche E, Gauthier Y, Drouin J Mol Cell Biol. 2003; 23(3):763-76.

PMID: 12529383 PMC: 140697. DOI: 10.1128/MCB.23.3.763-776.2003.